BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 20, 2002
View Archived Issues
Neotrofin protects against neurodegeneration in a rat model of Parkinson's disease
Read More
Once-weekly antidepressant safe and effective in natural clinical setting
Read More
Inhibition of UL70 primase as a promising approach to the treatment of cytomegalovirus infections
Read More
QYL-1064 and analogues effective against cytomegalovirus and certain other herpesviruses
Read More
UMJD-1369 identified as a potent, early-acting anti-HCMV pyrrolopyrimidine
Read More
Results reported in Barcelona for DNA and protein AutoVac HER-2 vaccines
Read More
Ezetimibe further improves lipoprotein profiles in statin-treated hypercholesterolemic patients
Read More
Compounds that prevent peptide metabolism reported by Sumitomo
Read More
Sankyo describes novel immunosuppressants in a recent patent
Read More
Steroid sulfatase inhibitors disclosed by Nippon Organon
Read More
Scientists at Aventis describe a new series of antidiabetic compounds
Read More
Melacure Therapeutics discloses melanocortin receptor ligands and their use
Read More
Novel LPS inhibitors synthesized at Mitsubishi Pharma
Read More
Ligand reports on 2001 highlights
Read More
Inex offers 2001 update
Read More
Swiss approval and launch of Tracleer announced
Read More
Amersham Health reports good progress in a number of areas during 2001
Read More
Zelnorm/Zelmac approved in Canada and Brazil
Read More
deCODE completes MediChem acquisition
Read More
Health Canada approves expanded label for ProstaScint
Read More
Boston Life Sciences initiates phase II study of Altropane for ADHD diagnosis
Read More
PowderJect to sell drug business to AlgoRx
Read More
PH-50 uptake in animal soft plaque tissue encouraging for early diagnosis of coronary artery disease
Read More
Encouraging results emerge from pilot phase III trial of Chronogesic
Read More